Events
Event sees new Memorandum of Understanding signed by PROLMED and KPTA.
ASLAN Pharmaceuticals announced late-breaking topline data from a phase 2 study conducted in China testing varlitinib and capecitabine in second line BTC patients.
Helsinn and Recordati Rare Diseases announce that a co-sponsored Symposium, organized by the two companies at the European Society for Dermatological Research Annual Meeting, , will provide a better knowledge of Chlormethine Gel’s mode of action as well as guidance on the management of the Chlormethine gel induced dermatitis.
Molecular Health, a leading company in the field of data science for precision medicine and specializing in the development of products and services leveraging its proprietary biomedicine technology platform Dataome, is due to participate in several upcoming conferences between September and December, 2019.
MagForce AG, a leading medical device company in the field of nanomedicine focused on oncology, is pleased to announce that it will host a scientific lunch symposium titled “Local Therapies in Malignant Gliomas - update and new perspectives” during the 19th European Congress of Neurosurgery in Dublin, Ireland.
TherOx announces key data presentations and company-sponsored events for SuperSaturated Oxygen (SSO2) Therapy at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium Sept. 25-29 at the Moscone Center in San Francisco.
According to the Office of National Drug Control Policy, 2,500 kids, age 12-17, are misusing prescription painkillers for the first time every day.
Data to be presented at inaugural STORM Therapeutics RNA Epigenetics in Human Disease Conference in Cambridge, UK
MR Solutions’ latest liquid helium free PET-MR preclinical imaging system for the molecular research community was the subject of talks and papers on simultaneous PET-MR imaging at the World Molecular Imaging Congress held in Montreal in September.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced multiple data presentations from its solid tumour portfolio, including key prostate cancer data, will be featured at the European Society for Medical Oncology 2019 Annual Congress, taking place 27th September to 1st October in Barcelona, Spain.
PRESS RELEASES